SEC Filing · 144
Neumora Therapeutics, Inc.
NMRANASDAQEQUITYCurrent
SEC Filing
Company context
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the greatest medical challenges of our generation by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our therapeutic pipeline currently consists of programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases. Neumora’s mission is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients.
Current securities
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗